Tapewire

Nasdaq · USD

VNDA

Vanda Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
5861
SEC CIK
0001347178
Parsed reports
233

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202605
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 3, 2022 02:28 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 6,974 $11.19 $78,059.98
Disclosure

SEC source: 0001209191-22-015158 · doc4.xml · nonDerivative · entry 2

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,278

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.15 to $11.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 02:27 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 29,588 $11.15 $329,944.66
Disclosure

SEC source: 0001209191-22-015157 · doc4.xml · nonDerivative · entry 3

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,352,766

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:27 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 3,473 $11.19 $38,862.87
Disclosure

SEC source: 0001209191-22-015155 · doc4.xml · nonDerivative · entry 2

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,523

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:26 UTC
Birznieks GuntherSVP, Business Development
SaleCommon Stock 4,084 $11.19 $45,699.96
Disclosure

SEC source: 0001209191-22-015154 · doc4.xml · nonDerivative · entry 2

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,324

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 02:27 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 7,508 $11.19 $84,014.52
Disclosure

SEC source: 0001209191-22-015157 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,382,354

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:27 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-22-015155 · doc4.xml · derivative · entry 5

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2032-02-27

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:27 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015155 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,996

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:29 UTC
Williams TimothySVP & General Counsel
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-22-015160 · doc4.xml · derivative · entry 3

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2032-02-27

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:29 UTC
Williams TimothySVP & General Counsel
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015160 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,911

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:26 UTC
Birznieks GuntherSVP, Business Development
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-22-015154 · doc4.xml · derivative · entry 4

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2032-02-27

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:26 UTC
Birznieks GuntherSVP, Business Development
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015154 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,408

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:28 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-22-015158 · doc4.xml · derivative · entry 3

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2032-02-27

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:28 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015158 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,252

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:27 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
GrantStock Option (Right to Buy) · Derivative 275,000 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-22-015157 · doc4.xml · derivative · entry 4

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2032-02-27

F4 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 28, 2023, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 02:27 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
GrantCommon Stock 115,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015157 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,389,862

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2023, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 71,676 $0.00 Strike: $4.88 $0.00
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · derivative · entry 6

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 71,676 shares

Expires 2021-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in 48 equal monthly installments beginning on January 6, 2012.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 46,200 $16.00 $739,347.84
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · nonDerivative · entry 4

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,274,862

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 5, 2021 as reflected in this Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.70 to $16.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionCommon Stock 71,676 $4.88 $349,778.88
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · nonDerivative · entry 3

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,321,062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 78,324 $0.00 Strike: $4.88 $0.00
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · derivative · entry 5

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,676

Underlying: Common Stock · 78,324 shares

Expires 2021-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in 48 equal monthly installments beginning on January 6, 2012.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
SaleCommon Stock 50,000 $16.49 $824,275.00
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,249,386

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 5, 2021 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 21:31 UTC
Polymeropoulos Mihael HristosDirector · President and CEO
Exercise / conversionCommon Stock 78,324 $4.88 $382,221.12
Disclosure

SEC source: 0001209191-21-067592 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,299,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 12:52 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,842 $0.00 Strike: $11.32 $0.00
Disclosure

SEC source: 0001209191-21-056530 · doc4.xml · derivative · entry 5

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,158

Underlying: Common Stock · 7,842 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person remains continuously employed by the Issuer through the applicable vesting date.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 12:52 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,277 $0.00 Strike: $12.27 $0.00
Disclosure

SEC source: 0001209191-21-056530 · doc4.xml · derivative · entry 4

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,224

Underlying: Common Stock · 4,277 shares

Expires 2029-07-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested with respect to 25% of the underlying shares on July 25, 2020, with the remaining 75% of the shares vesting in 36 equal monthly installments beginning August 25, 2020, provided the Reporting Person remains continuously employed by the Issuer through each monthly vesting date.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 12:52 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 16,824 $16.49 $277,394.11
Disclosure

SEC source: 0001209191-21-056530 · doc4.xml · nonDerivative · entry 3

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,980

F1 · kind: A portion of the shares was sold to satisfy the exercise price and tax obligations relating to the acquisition of the shares in connection with the stock option exercise.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 12:52 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionCommon Stock 7,842 $11.32 $88,771.44
Disclosure

SEC source: 0001209191-21-056530 · doc4.xml · nonDerivative · entry 2

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 12:52 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionCommon Stock 4,277 $12.27 $52,478.79
Disclosure

SEC source: 0001209191-21-056530 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 20:40 UTC Exercise / conversionStock Option (right to buy) · Derivative 13,124 $0.00 Strike: $12.70 $0.00
Disclosure

SEC source: 0001209191-21-055685 · doc4.xml · derivative · entry 5

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,876

Underlying: Common Stock · 13,124 shares

Expires 2030-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested with respect to 25% of the underlying shares on February 14, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 20:40 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,985 $0.00 Strike: $10.57 $0.00
Disclosure

SEC source: 0001209191-21-055685 · doc4.xml · derivative · entry 4

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,985 shares

Expires 2030-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 20:40 UTC SaleCommon Stock 19,109 $16.74 $319,976.38
Disclosure

SEC source: 0001209191-21-055685 · doc4.xml · nonDerivative · entry 3

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,215

F1 · kind: A portion of the shares was sold to satisfy the exercise price of the stock options.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.53 to $16.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 20:40 UTC Exercise / conversionCommon Stock 13,124 $12.70 $166,674.80
Disclosure

SEC source: 0001209191-21-055685 · doc4.xml · nonDerivative · entry 2

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 20:40 UTC Exercise / conversionCommon Stock 5,985 $10.57 $63,261.45
Disclosure

SEC source: 0001209191-21-055685 · doc4.xml · nonDerivative · entry 1

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2021 Filed Aug 23, 2021 20:36 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 3,650 $15.39 $56,189.56
Disclosure

SEC source: 0001209191-21-052965 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,552

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.30 to $15.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:31 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 3,715 $16.15 $59,988.71
Disclosure

SEC source: 0001209191-21-051865 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,211

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
July 28, 2021 Filed Jul 30, 2021 09:15 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 2,130 $19.24 $40,972.89
Disclosure

SEC source: 0001209191-21-048738 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,296

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.22 to $19.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
July 26, 2021 Filed Jul 27, 2021 20:37 UTC
Jones Aranthan IIChief Corp. Affairs Officer
SaleCommon Stock 7,250 $19.69 $142,776.43
Disclosure

SEC source: 0001209191-21-048276 · doc4.xml · nonDerivative · entry 1

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,685

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.61 to $19.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:01 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,015 $0.00 Strike: $10.57 $0.00
Disclosure

SEC source: 0001209191-21-041496 · doc4.xml · derivative · entry 3

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,985

Underlying: Common Stock · 4,015 shares

Expires 2030-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:01 UTC SaleCommon Stock 5,000 $19.42 $97,122.00
Disclosure

SEC source: 0001209191-21-041496 · doc4.xml · nonDerivative · entry 2

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,215

F1 · kind: A portion of the shares was sold to satisfy the exercise price of the stock option and the tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:01 UTC Exercise / conversionCommon Stock 4,015 $10.57 $42,438.55
Disclosure

SEC source: 0001209191-21-041496 · doc4.xml · nonDerivative · entry 1

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,215

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2021 Filed Jun 15, 2021 20:42 UTC SaleCommon Stock 2,075 $19.34 $40,132.16
Disclosure

SEC source: 0001209191-21-040615 · doc4.xml · nonDerivative · entry 1

Chrousos Phaedra · CIK 0001774518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,925

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.33 to $19.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:35 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001209191-21-040237 · doc4.xml · derivative · entry 2

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:35 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040237 · doc4.xml · nonDerivative · entry 1

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,887

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 16:37 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001209191-21-040244 · doc4.xml · derivative · entry 2

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 16:37 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040244 · doc4.xml · nonDerivative · entry 1

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,505

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:36 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001209191-21-040243 · doc4.xml · derivative · entry 2

Ward Anne Sempowski · CIK 0001790117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:36 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040243 · doc4.xml · nonDerivative · entry 1

Ward Anne Sempowski · CIK 0001790117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:36 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001209191-21-040240 · doc4.xml · derivative · entry 2

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:36 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040240 · doc4.xml · nonDerivative · entry 1

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,200

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:34 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $19.21 $0.00
Disclosure

SEC source: 0001209191-21-040236 · doc4.xml · derivative · entry 2

Chrousos Phaedra · CIK 0001774518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:34 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040236 · doc4.xml · nonDerivative · entry 1

Chrousos Phaedra · CIK 0001774518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
March 15, 2021 Filed Mar 16, 2021 20:20 UTC
Jones Aranthan IIChief Corp. Affairs Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $11.32 $0.00
Disclosure

SEC source: 0001209191-21-020782 · doc4.xml · derivative · entry 3

Jones Aranthan II · CIK 0001785894 · Chief Corp. Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 15,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.